Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Patients who have had a first episode of unprovoked venous thromboembolism have a high risk of recurrence after anticoagulants are discontinued. Aspirin may be effective in preventing a recurrence of venous thromboembolism. METHODS: We randomly assigned 822 patients who had completed initial anticoagulant therapy after a first episode of unprovoked venous thromboembolism to receive aspirin, at a dose of 100 mg daily, or placebo for up to 4 years. The primary outcome was a recurrence of venous thromboembolism. RESULTS: During a median follow-up period of 37.2 months, venous thromboembolism recurred in 73 of 411 patients assigned to placebo and in 57 of 411 assigned to aspirin (a rate of 6.5% per year vs. 4.8% per year; hazard ratio with aspirin, 0.74; 95% confidence interval [CI], 0.52 to 1.05; P=0.09). Aspirin reduced the rate of the two prespecified secondary composite outcomes: the rate of venous thromboembolism, myocardial infarction, stroke, or cardiovascular death was reduced by 34% (a rate of 8.0% per year with placebo vs. 5.2% per year with aspirin; hazard ratio with aspirin, 0.66; 95% CI, 0.48 to 0.92; P=0.01), and the rate of venous thromboembolism, myocardial infarction, stroke, major bleeding, or death from any cause was reduced by 33% (hazard ratio, 0.67; 95% CI, 0.49 to 0.91; P=0.01). There was no significant between-group difference in the rates of major or clinically relevant nonmajor bleeding episodes (rate of 0.6% per year with placebo vs. 1.1% per year with aspirin, P=0.22) or serious adverse events. CONCLUSIONS: In this study, aspirin, as compared with placebo, did not significantly reduce the rate of recurrence of venous thromboembolism but resulted in a significant reduction in the rate of major vascular events, with improved net clinical benefit. These results substantiate earlier evidence of a therapeutic benefit of aspirin when it is given to patients after initial anticoagulant therapy for a first episode of unprovoked venous thromboembolism. (Funded by National Health and Medical Research Council [Australia] and others; Australian New Zealand Clinical Trials Registry number, ACTRN12605000004662.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consequently, several studies have investigated the role of aspirin for the secondary prevention of VTE. 309,314,315”
From American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism (2020) · cites this paper as [315]
In the citing paper
“The WARFASA 309 and ASPIRE 318 trials compared aspirin, 100 mg daily, with placebo for secondary prevention of recurrent VTE for patients with an initial unprovoked event, and the pooled results of the 2 trials showed a decrease in recurrent VTE, as well as major vascular events, without an increased risk for clinically relevant bleeding. 309,315”
From American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism (2020) · cites this paper as [315]
Citations
Cites
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Systematic Reviews in Health Care : Meta-Analysis in Context
Egger, M., Smith, G. D., & Altman, D. G. (2000) · Cited by 2,401
The Long-Term Clinical Course of Acute Deep Venous Thrombosis
Prandoni, P., Lensing, A. W. A., Cogo, A., Cuppini, S., Villalta, S., Carta, M., Cattelan, A. M., Polistena, P., Bernardi, E., & Prins, M. H. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00001 · Cited by 2,109
Systematic Reviews in Health Care: Meta‐Analysis in Context
(2001) · doi:10.1002/9780470693926 · Cited by 1,693
Heit, J. A., Mohr, D. N., Silverstein, M. D., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.761 · Cited by 1,352
(2000) · The Lancet · doi:10.1016/s0140-6736(00)02110-3 · Cited by 1,076
Kearon, C., Gent, M., Hirsh, J., Weitz, J., Kovacs, M. J., Anderson, D. R., Turpie, A. G., Green, D., Ginsberg, J. S., Wells, P., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903253401201 · Cited by 1,072
Determinants and Time Course of the Postthrombotic Syndrome after Acute Deep Venous Thrombosis
Kahn, S. R., Shrier, I., Julian, J. A., Ducruet, T., Arsenault, L., Miron, M.-J., Roussin, A., Desmarais, S., Joyal, F., Kassis, J., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-10-200811180-00004 · Cited by 854
Linkins, L.-A., Choi, P. T., & Douketis, J. D. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-11-200312020-00007 · Cited by 764
Cited by
Items 101–200 of 600
Skeith, L., Carrier, M., Robinson, S. E., Alimam, S., & Rodger, M. A. (2017) · Blood · doi:10.1182/blood-2016-09-728006 · Cited by 47
Elwood, P. C., Pickering, J. E., Morgan, G., Galante, J., Weightman, A. L., Morris, D., Longley, M., Mason, M., Adams, R., Dolwani, S., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0203957 · Cited by 43
Arrington‐Sanders, R., Connell, N. T., Coon, D., Dowshen, N., Goldman, A. L., Goldstein, Z. G., Grimstad, F. W., Javier, N. M., Kim, E., Murphy, M. C., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.12.008 · Cited by 46
Pan, Z., Wang, B., Zhang, R., Wang, S., Li, Y., & Li, Y. (2023) · IEEE Transactions on Signal Processing · doi:10.1109/tsp.2023.3242091 · Cited by 45
Goto, S., Hasebe, T., & Takagi, S. (2015) · Circulation Journal · doi:10.1253/circj.cj-14-1434 · Cited by 45
Bleker, S. M., van Es, N., van Gils, L., Daams, J. G., Kleinjan, A., Buller, H. R., & Nisio, M. D. (2016) · Thrombosis Research · doi:10.1016/s0049-3848(16)30104-9 · Cited by 45
Bradbury, C. A., Fletcher, K., Sun, Y., Heneghan, C. J., Gardiner, C., Roalfe, A. K., Hardy, P., McCahon, D., Heritage, G., Shackleford, H., et al. (2019) · British Journal of Haematology · doi:10.1111/bjh.16275 · Cited by 44
Cavallari, I., Morrow, D. A., Creager, M. A., Olin, J. W., Bhatt, D. L., Steg, P. G., Storey, R. F., Cohen, M. C., Scirica, B. S., Piazza, G., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.031062 · Cited by 43
Wu, C. M., Alotaibi, G., AlSaleh, K. A., Linkins, L., & McMurtry, M. S. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.10.033 · Cited by 43
Sobieraj, D. M., Coleman, C. I., Pasupuleti, V., Deshpande, A., Kaw, R., & Hernandez, A. V. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.02.032 · Cited by 42
Long-term clinical course of acute pulmonary embolism
den Exter, P. L., van der Hulle, T., Lankeit, M., Huisman, M. V., & Klok, F. A. (2013) · Blood Reviews · doi:10.1016/j.blre.2013.06.003 · Cited by 42
Han, K., Li, G., Fang, Z., & Yang, F. (2023) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2023.3344384 · Cited by 40
Antiplatelet agents for the treatment of deep venous thrombosis
Flumignan, C. D. Q., Nakano, L. C. U., Baptista-Silva, J. C., & Flumignan, R. L. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012369.pub2 · Cited by 40
Venous and Arterial Thrombosis: Is There a Link?
Prandoni, P. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_121 · Cited by 40
Venous thromboembolism: Predicting recurrence and the need for extended anticoagulation
Barnes, G. D., Kanthi, Y. M., & Froehlich, J. B. (2015) · Vascular Medicine · doi:10.1177/1358863x14566429 · Cited by 40
Uresandi, F., Monréal, M., García-Bragado, F., Domenech, P., Lecumberri, R., Escribano, P., Zamorano, J. L., Jiménez, S., Ruiz‐Artacho, P., Lozano, F., et al. (2013) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2013.10.008 · Cited by 40
CGMatch: A Different Perspective of Semi-supervised Learning
Cheng, B., Lu, J., Tian, Y., Zhao, H., Chang, Y., & Du, L. (2025) · IEEE Computer Society Conference on Computer Vision and Pattern Recognition/Proceedings - IEEE Computer Society Conference on Computer Vision and Pattern Recognition/Proceedings · doi:10.1109/cvpr52734.2025.01433 · Cited by 39
Панченко, Е. П., Balahonova, T. V., Danilov, N. M., Komarov, A. L., Станиславовна, К. Е., Saidova, M. A., Shakhmatova, O. O., & Yavelov, I. S. (2021) · Eurasian heart journal · doi:10.38109/2225-1685-2021-1-44-77 · Cited by 39
Increased risk of CVD after VT is determined by common etiologic factors
Roach, R. E. J., Lijfering, W. M., Flinterman, L. E., Rosendaal, F. R., & Cannegieter, S. C. (2013) · Blood · doi:10.1182/blood-2013-01-479238 · Cited by 39
Chang, R., Scerbo, M. H., Schmitt, K. M., Adams, S. D., Choi, T. J., Wade, C. E., & Holcomb, J. B. (2017) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000001675 · Cited by 39
Hsu, C.-Y., Lin, Y.-S., Su, Y.-J., Lin, H.-F., Lin, M.-S., Syu, Y.-J., Cheng, T.-T., Yu, S.-F., Chen, J.-F., & Chen, T.-H. (2017) · Rheumatology · doi:10.1093/rheumatology/kex357 · Cited by 38
Aspirin for primary prevention of cardiovascular disease
Nansseu, J. R., & Noubiap, J. J. (2015) · Thrombosis Journal · doi:10.1186/s12959-015-0068-7 · Cited by 38
Extended Anticoagulation for VTE
Mai, V., Guay, C.-A., Perreault, L., Bonnet, S., Bertoletti, L., Lacasse, Y., Mainbourg, S., Lega, J., & Provencher, S. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.02.402 · Cited by 38
Recommendations from the ICM-VTE: General
Delegates, T. I.-V. G. (2022) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.21.01531 · Cited by 38
Cohen, A. T., Imfeld, S., Markham, J., & Granziera, S. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.11.036 · Cited by 38
Lötsch, F., Königsbrügge, O., Posch, F., Zielinski, C. C., Pabinger, I., & Ay, C. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.09.001 · Cited by 38
Huang, Z., Jiang, R., Aeron, S., & Hughes, M. C. (2024) · IEEE Computer Society Conference on Computer Vision and Pattern Recognition/Proceedings - IEEE Computer Society Conference on Computer Vision and Pattern Recognition/Proceedings · doi:10.1109/cvpr52733.2024.02103 · Cited by 36
Hansen-Krone, I. J., Enga, K. F., Sudduth-Klinger, J., Mathiesen, E. B., Njølstad, I., Wilsgaard, T., Watkins, S. M., Brækkan, S. K., & Hansen, J. (2014) · Journal of Nutrition · doi:10.3945/jn.113.189548 · Cited by 36
Resuming anticoagulation after hemorrhage: A practical approach
Colantino, A., Jaffer, A. K., & Brotman, D. J. (2015) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.82a.14047 · Cited by 35
Mai, V., Bertoletti, L., Cucherat, M., Mainbourg, S., Grangé, C., Provencher, S., & Lega, J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214134 · Cited by 35
Farias, S., & Boateng, J. S. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119807 · Cited by 35
Mwiza, J.-M., Lee, R. H., Paul, D. S., Holle, L. A., Cooley, B. C., Nieswandt, B., Schug, W. J., Kawano, T., Mackman, N., Wolberg, A. S., et al. (2022) · Blood · doi:10.1182/blood.2022015787 · Cited by 35
Heestermans, M., Salloum‐Asfar, S., Streef, T. J., Laghmani, E. H., Salvatori, D. C. F., Luken, B. M., Zeerleder, S. S., Spronk, H. M. H., Korporaal, S. J. A., Kirchhofer, D., et al. (2019) · Blood · doi:10.1182/blood-2018-06-853762 · Cited by 34
Prevention of early complications following total hip replacement
Fontalis, A., Berry, D. J., Shimmin, A., Slullitel, P. A., Buttaro, M. A., Cao, L., Malchau, H., & Haddad, F. S. (2021) · SICOT-J · doi:10.1051/sicotj/2021060 · Cited by 33
Bokshan, S. L., DeFroda, S. F., Panarello, N. M., & Owens, B. D. (2018) · Orthopaedic Journal of Sports Medicine · doi:10.1177/2325967118781328 · Cited by 33
Lewis, T. C., Cortes, J. E., Altshuler, D., & Papadopoulos, J. (2018) · Journal of Intensive Care Medicine · doi:10.1177/0885066618796486 · Cited by 33
Christiansen, M., Grove, E. L., & Hvas, A. (2021) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0041-1726096 · Cited by 32
Long-Term Management of Pulmonary Embolism: A Review of Consequences, Treatment, and Rehabilitation
Højen, A. A., Nielsen, P. B., Overvad, T. F., Albertsen, I. E., Klok, F. A., Rolving, N., Søgaard, M., & Ording, A. G. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11195970 · Cited by 32
Risk of Venous Thromboembolism in Patients by Albuminuria and Estimated GFR
Massicotte‐Azarniouch, D., Eddeen, A. B., Lazo‐Langner, A., Molnar, A. O., Lam, N. N., McCallum, M. K., Bota, S. E., Zimmerman, D. L., Garg, A. X., Harel, Z., et al. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.07.003 · Cited by 33
Haykal, T., Barbarawi, M., Zayed, Y., Yelangi, A., Dhillon, H., Goranta, S., Kheiri, B., Chahine, A., Samji, V., Kerbage, J., et al. (2019) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-019-02932-0 · Cited by 31
Safety of gastrointestinal endoscopic biopsy in patients taking antithrombotics
Fujita, M., Shiotani, A., Murao, T., Ishii, M., Yamanaka, Y., Nakato, R., Matsumoto, H., Tarumi, K., Manabe, N., Kamada, T., et al. (2014) · Digestive Endoscopy · doi:10.1111/den.12303 · Cited by 31
Platelets as Central Actors in Thrombosis—Reprising an Old Role and Defining a New Character
Stevens, H., & McFadyen, J. D. (2019) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0039-1698829 · Cited by 31
Contemporary rates of inferior vena cava filter thrombosis and risk factors
King, R. W., Wooster, M., Veeraswamy, R. K., & Genovese, E. A. (2021) · Journal of Vascular Surgery Venous and Lymphatic Disorders · doi:10.1016/j.jvsv.2021.07.016 · Cited by 30
Immediate and delayed complications of inferior vena cava filters
Ramakrishnan, G., Willie-Permor, D., Yei, K. S., Nejim, B. J., Enumah, Z. O., Gasparis, A. P., & Malas, M. B. (2022) · Journal of Vascular Surgery Venous and Lymphatic Disorders · doi:10.1016/j.jvsv.2022.08.011 · Cited by 30
Piazza, G. (2015) · Vascular Medicine · doi:10.1177/1358863x14568706 · Cited by 30
Douketis, J. D. (2016) · Internal and Emergency Medicine · doi:10.1007/s11739-016-1553-0 · Cited by 30
Zhu, Y., Wang, F., Zhao, Y., Wang, P., & Sang, S. (2017) · Scientific Reports · doi:10.1038/srep40119 · Cited by 30
Somigliana, E., Peccatori, F. A., Filippi, F., Martinelli, F., Raspagliesi, F., & Martinelli, I. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu035 · Cited by 30
Minno, M. N. D. D., Calcaterra, I. L., Papa, A., Lupoli, R., Minno, A. D., Maniscalco, M., & Ambrosino, P. (2021) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2021.04.004 · Cited by 29
Robertson, L., Yeoh, S. E., & Ramli, A. H. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011088.pub2 · Cited by 29
The 125th Anniversary of Aspirin—The Story Continues
Werz, O., Stettler, H., Theurer, C., & Seibel, J. (2024) · Pharmaceuticals · doi:10.3390/ph17040437 · Cited by 28
Extended anticoagulation after venous thromboembolism: should it be done?
Fernandes, C. J. C. D. S., Calderaro, D., Piloto, B. M., Hoette, S., Jardim, C., & Souza, R. (2019) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753466619878556 · Cited by 28
Recent developments in the diagnosis and treatment of pulmonary embolism
van der Hulle, T., Dronkers, C. E. A., Klok, F. A., & Huisman, M. V. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12404 · Cited by 28
Assessing recurrence risk following acute venous thromboembolism: use of algorithms
Poli, D., & Palareti, G. (2013) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328363ed7c · Cited by 28
Overview of Venous Thrombosis in Inflammatory Bowel Disease
Pürnak, T., & Yüksel, O. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000274 · Cited by 28
Succinct Review of the New VTE Prevention and Management Guidelines
Pollak, A. W., & McBane, R. D. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.11.015 · Cited by 28
Developments in the management and treatment of pulmonary embolism
Limbrey, R., & Howard, L. (2015) · European Respiratory Review · doi:10.1183/16000617.00006614 · Cited by 28
Vázquez-Santiago, M., Vilalta, N., Cuevas, B., Murillo, J., Llobet, D., Macho, R., Pujol‐Moix, N., Carrasco, M., Mateo, J., Fontcuberta, J., et al. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.07.012 · Cited by 28
Lazo‐Langner, A., Fleet, J. L., McArthur, E., & Garg, A. X. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12675 · Cited by 28
Diretrizes sobre trombose venosa profunda da Sociedade Brasileira de Angiologia e Cirurgia Vascular
Sobreira, M. L., Marques, M. A., Paschôa, A. F., Ribeiro, A. J. A., Casella, I. B., Burihan, M. C., Matielo, M. F., Soares, R. D. A., de Araújo, W. J. B., Joviliano, E. É., et al. (2024) · Jornal Vascular Brasileiro · doi:10.1590/1677-5449.202301071 · Cited by 27
Castellucci, L. A., Gal, G. L., Rodger, M. A., & Carrier, M. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12501 · Cited by 27
Risk assessment for recurrence and optimal agents for extended treatment of venous thromboembolism
Agnelli, G., & Becattini, C. (2013) · Hematology · doi:10.1182/asheducation-2013.1.471 · Cited by 27
Platelet function as a risk factor for venous thromboembolism in the Framingham Heart Study
Puurunen, M. K., Hwang, S., O'Donnell, C. J., Tofler, G. H., & Johnson, A. D. (2017) · Thrombosis Research · doi:10.1016/j.thromres.2017.01.010 · Cited by 27
Tomkowski, W. Z., Kuca, P., Urbanek, T., Chmielewski, D., Krasiński, Z., Pruszczyk, P., Windyga, J., Oszkinis, G., Jawień, A., Burakowski, J., et al. (2017) · Acta Angiologica · doi:10.5603/aa.2017.0008 · Cited by 27
Orsi, F. A., Lijfering, W. M., van der Laarse, A., Ruhaak, L. R., Rosendaal, F. R., Cannegieter, S. C., & Cobbaert, C. M. (2019) · Clinical Epidemiology · doi:10.2147/clep.s196266 · Cited by 27
Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants
Bavalia, R., Middeldorp, S., Weißer, G., & Espinola–Klein, C. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1710314 · Cited by 26
Prandoni, P., Barbar, S., Milan, M., Vedovetto, V., & Pesavento, R. (2013) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2013.09.005 · Cited by 26
Barbar, S., Milan, M., Campello, E., Spiezia, L., Piovella, C., Pesavento, R., & Prandoni, P. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-04-0396 · Cited by 26
Thromboprophylaxis in Head and Neck Microvascular Reconstruction
Abraham, M. T., Badhey, A. K., Hu, S., Kadakia, S., Rasamny, J. K., Moscatello, A. L., & Ducic, Y. (2017) · Craniomaxillofacial Trauma & Reconstruction · doi:10.1055/s-0037-1607068 · Cited by 26
Update on extended treatment for venous thromboembolism
Peñaloza-Martínez, E., Rodríguez, P. D., Proietti, M., Fernández‐Llamazares, G. S., Mendo, C. L., Álvarez-Sala, J. L., Marra, A. M., & del Toro‐Cervera, J. (2018) · Annals of Medicine · doi:10.1080/07853890.2018.1538564 · Cited by 26
Veettil, S. K., Jinatongthai, P., Nathisuwan, S., Teerawattanapong, N., Ching, S. M., Lim, K. G., Saokaew, S., Phisalprapa, P., Reid, C. M., & Chaiyakunapruk, N. (2018) · Clinical Epidemiology · doi:10.2147/clep.s174120 · Cited by 26
Valeriani, E., Porreca, E., Weitz, J. I., Schulman, S., Candeloro, M., & Nisio, M. D. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14807 · Cited by 26
Asociación entre enfermedad tromboembólica venosa y dislipidemia
García‐Raso, A., Ene, G. S., Miranda, C., Vidal, R., Mata, R., & Sillero, M. P. L. (2013) · Medicina Clínica · doi:10.1016/j.medcli.2013.07.024 · Cited by 25
Konstantinides, S., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D. A., Galiè, N., Gibbs, J. S. R., Huisman, M. V., Humbert, M. J. C., Kucher, N., et al. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2014.12.002 · Cited by 25
Hypercoagulability in Cushing’s syndrome: From arterial to venous disease
St‐Jean, M., Lim, D. S. T., & Langlois, F. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101496 · Cited by 25
Dobesh, P. P., & Fanikos, J. R. (2014) · Drugs · doi:10.1007/s40265-014-0301-x · Cited by 24
Heller, S., Secrist, E. S., Shahi, A., Chen, A. F., & Parvizi, J. (2016) · The Journal of Arthroplasty · doi:10.1016/j.arth.2015.12.042 · Cited by 24
Tang, A., Zak, S. G., Iorio, R. R., Slover, J. D., Bosco, J. A., & Schwarzkopf, R. M. (2020) · The Journal of Arthroplasty · doi:10.1016/j.arth.2020.03.040 · Cited by 24
Superficial phlebitis and thrombophlebitis
Redaktsiia (2021) · Journal of Venous Disorders · doi:10.17116/flebo202115031211 · Cited by 24
Ashrani, A. A., Barsoum, M. K., Crusan, D. J., Petterson, T. M., Bailey, K. R., & Heit, J. A. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.04.005 · Cited by 24
Liu, S., Shen, Y., Chen, J., Ruan, Z., Li, H., Wang, K., Xi, X., & Mao, J. (2025) · Blood Reviews · doi:10.1016/j.blre.2025.101302 · Cited by 24
New oral anticoagulants for the treatment of venous thromboembolism
Agnelli, G., Becattini, C., & Franco, L. (2013) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2013.07.005 · Cited by 23
Aspirin Is Associated With Reduced Rates of Venous Thromboembolism in Older Patients With Cancer
Li, P., Ning, Y., Li, M., Cai, P., Siddiqui, A. D., Liu, E. Y., Hadley, M. L., Wu, F., Pan, S. F., Dixon, R. A. F., et al. (2020) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248420925021 · Cited by 23
Krauss, E. S., Cronin, M., Dengler, N., & Segal, A. (2020) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029620920373 · Cited by 23
Barra, S., Paiva, L., Providencia, R. A., Fernandes, A. S., & Marques, A. L. (2013) · Clinical Cardiology · doi:10.1002/clc.22144 · Cited by 23
Amadio, P., Tarantino, E., Sandrini, L., Tremoli, E., & Barbieri, S. S. (2017) · Thrombosis and Haemostasis · doi:10.1160/th16-12-0968 · Cited by 23
Seagrave, K. G., Fletcher, J., & Hitos, K. (2020) · International Angiology · doi:10.23736/s0392-9590.19.04086-0 · Cited by 22
An Incremental-Self-Training-Guided Semi-Supervised Broad Learning System
Guo, J., Liu, Z., & Chen, C. L. P. (2024) · IEEE Transactions on Neural Networks and Learning Systems · doi:10.1109/tnnls.2024.3392583 · Cited by 22
Yang, W., Deng, C., Liu, P., Hu, Y., Luo, Z. Y., & Cai, K. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.03.055 · Cited by 22
Involvement of Inflammation in Venous Thromboembolic Disease: An Update in the Age of COVID-19
Poredoš, P., & Poredoš, P. (2021) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0041-1732372 · Cited by 22
Influence of coronary artery disease-associated genetic variants on risk of venous thromboembolism
Bruzelius, M., Strawbridge, R. J., Trégouët, D., Wiggins, K. L., Gertow, K., Sabater‐Lleal, M., Öhrvik, J., Bergendal, A., Silveira, A. M. V., Sundström, A., et al. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.03.054 · Cited by 22
Optimal treatment duration of venous thrombosis
Ageno, W., Dentali, F., Donadini, M. P., & Squizzato, A. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12234 · Cited by 21
Prandoni, P. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.05.013 · Cited by 21
Snir, O., Wilsgård, L., Latysheva, N., Wahlund, C. J. E., Brækkan, S. K., Hindberg, K., & Hansen, J. (2022) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15638 · Cited by 21
Aspirin as added prophylaxis for deep vein thrombosis in trauma: A retrospective case-control study
Brill, J. B., Calvo, R. Y., Wallace, J. D., Lewis, P. R., Bansal, V., Sise, M. J., & Shackford, S. R. (2016) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000000977 · Cited by 21
Tarango, C., Schulman, S., Betensky, M., & Goldenberg, N. A. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2018.1407241 · Cited by 21
Pompilio, G., Integlia, D., Raffetto, J. D., & Palareti, G. (2020) · TH Open · doi:10.1055/s-0040-1709731 · Cited by 21
y, P. A., Bayés‐Genís, A., de Isla, L. P., Sanchís, J. M., & Heras, M. (2012) · Revista Española de Cardiología · doi:10.1016/j.recesp.2012.11.004 · Cited by 20
Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review
van der Wall, S. J., van der Pol, L. M., Ende-Verhaar, Y. M., Cannegieter, S. C., Schulman, S., Prandoni, P., Rodger, M. A., Huisman, M. V., & Klok, F. A. (2018) · European Respiratory Review · doi:10.1183/16000617.0094-2018 · Cited by 20
Hounkpe, B. W., Benatti, R. O., Carvalho, B. S., & Paula, E. V. D. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235501 · Cited by 20
Metadata
- Authors
- Brighton, T. A., Eikelboom, J. W., Mann, K., Mister, R., Gallus, A., Ockelford, P., Gibbs, H., Hague, W., Xavier, D., Diaz, R., Kirby, A., & Simes, J.
- Affiliations
- Prince of Wales Hospital (AU)
- Population Health Research Institute (CA)
- The University of Sydney (AU)
- South Australia Pathology (AU)
- Auckland City Hospital (NZ)
- The Alfred Hospital (AU)
- St.John's Medical College Hospital (IN)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-11-22
- Volume
- 367
- Issue
- 21
- Pages
- 1979-1987
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2162531249
- Cited by
- 563
- References
- 24
- Citations by year
- 2026: 15 · 2025: 32 · 2024: 39 · 2023: 24 · 2022: 25 · 2021: 33 · 2020: 37 · 2019: 30 · 2018: 35 · 2017: 49 · 2016: 51 · 2015: 56 · 2014: 60 · 2013: 69 · 2012: 8
- FWCI
- 41.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- The Sydney eScholarship Repository (The University of Sydney) (submittedVersion)
- Topics
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- low-dose aspirin, venous thromboembolism, recurrence prevention, unprovoked venous thromboembolism, anticoagulation discontinuation, secondary prevention, cardiovascular events, bleeding risk, major vascular events, net clinical benefit, thromboprophylaxis, stroke, myocardial infarction
- MeSH terms
- Aspirin, Double-Blind Method, Female, Follow-Up Studies, Hemorrhage, Humans, Male, Middle Aged, Platelet Aggregation Inhibitors, Risk, Incidence, Venous Thromboembolism, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.